Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Benzoic acid, 5-bromo-2-(trifluoromethyl)-, methyl ester is a chemical compound with the molecular formula C9H6BrF3O2. It is a methyl ester derivative of benzoic acid that features a bromine atom and a trifluoromethyl group. Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester is known for its unique chemical properties, making it a versatile component in various chemical processes and syntheses.

842136-32-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 842136-32-7 Structure
  • Basic information

    1. Product Name: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester
    2. Synonyms: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester;Methyl 5-broMo-2-(trifluoroMethyl)benzoate;Methyl 5-bromo-2-(trifluoromethyl)
    3. CAS NO:842136-32-7
    4. Molecular Formula: C9H6BrF3O2
    5. Molecular Weight: 283.0419496
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 842136-32-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 280.9±40.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.598±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester(CAS DataBase Reference)
    10. NIST Chemistry Reference: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester(842136-32-7)
    11. EPA Substance Registry System: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester(842136-32-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 842136-32-7(Hazardous Substances Data)

842136-32-7 Usage

Uses

Used in Organic Synthesis:
Benzoic acid, 5-bromo-2-(trifluoromethyl)-, methyl ester is used as a reagent in organic synthesis for its distinctive chemical characteristics, facilitating the creation of a range of organic compounds.
Used in Pharmaceutical Production:
Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester serves as a building block in the production of pharmaceuticals, contributing to the development of new medications due to its specific structural features.
Used in Agrochemicals:
Benzoic acid, 5-bromo-2-(trifluoromethyl)-, methyl ester is also utilized in the creation of agrochemicals, playing a role in the synthesis of substances that help protect and enhance crop yields.
Used as an Intermediate in Industrial Applications:
Furthermore, it is employed as an intermediate in the synthesis of various compounds for industrial applications, showcasing its broad utility across different sectors.

Check Digit Verification of cas no

The CAS Registry Mumber 842136-32-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,2,1,3 and 6 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 842136-32:
(8*8)+(7*4)+(6*2)+(5*1)+(4*3)+(3*6)+(2*3)+(1*2)=147
147 % 10 = 7
So 842136-32-7 is a valid CAS Registry Number.

842136-32-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 5-bromo-2-(trifluoromethyl)benzoate

1.2 Other means of identification

Product number -
Other names CL9136

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:842136-32-7 SDS

842136-32-7Relevant articles and documents

ETHYNYL COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE FOR THE TREATMENT OF MALARIA

-

, (2019/01/21)

The present disclosure relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein R1 means a fluorine atom or a perhalogeno linear alkyl radical containing 1, 2 or 3 carbon atoms; R2 means a chlorine atom, a linear alkyl radical containing 1, 2 or 3 carbon atoms or a perhalogeno linear alkyl radical containing 1, 2 or 3 carbon atoms, and R means a hydrogen atom or a radical of formula (la). The present disclosure also relates to processes for their preparation as well their therapeutic uses, in particular such as for use in the treatment of malaria.

COMPOUND HAVING ZNF143 INHIBITORY ACTIVITY AND USE THEREOF

-

Paragraph 0275, (2016/10/27)

PROBLEM TO BE SOLVED: To provide a compound having a ZNF143 inhibitory activity as well as to provide a ZNF143 inhibitory agent and pharmaceutical composition containing the same. SOLUTION: Provided is a compound represented by formula (I) or a salt thereof as well as a ZNF143 inhibitory agent containing the same and a pharmaceutical composition having the same as an active ingredient. A-B-C-D (I)[A is H, a methyl group, a naphthyl group, a phenyl group or a nitrogen-containing heterocyclic ring; B is as shown below, and C is an amide bond or a heteroaromatic ring containing N and O; D is a substituted/unsubstituted phenyl group or a monocyclic heteroaromatic ring containing N or S; and C and D are both fused heterocyclic ring or the like optionally having a substituent group.]. SELECTED DRAWING: Figure 1 COPYRIGHT: (C)2016,JPOandINPIT

PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH

-

Page/Page column 101, (2009/09/04)

Provided herein are Pyrazole Pyrazine Amine Compounds having the following structure:Formula (I). Wherein Q and R1-R3 are as defined herein, compositions comprising an effective amount of a Pyrazole Pyrazine Amine Compound and methods for treating or preventing inflammatory conditions, immunological conditions, cancer, neurodegenerative diseases, age-related diseases, cardiovascular diseases and metabolic conditions, or conditions treatable or preventable by inhibition of an IKK, or an IKK pathway, comprising administering an effective amount of a Pyrazole Pyrazine Amine Compound to a patient in need thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 842136-32-7